Continued support is requested fora training program in Viral Oncology at Duke University Medical Center. The program has been funded since 1975 and this is a request for renewal for the fifth term of the program. Funds are requested for the support of 5 predoctoral trainees and 2 postdoctoral trainees. The participating faculty consists of 16 members of the Duke University Medical Center, the majority of which have primary or secondary appointments in the Department of Molecular Genetics and Microbiology. The additional participating faculty have appointments in the Departments of Medicine, Pediatrics, Surgery, Biochemistry or Pharmacology and Cancer Biology. The research interests of the participating faculty range from basic molecular genetic studies of animal virus replication, to the use of DNA animal viruses as model systems for the study of gene regulation in eukaryotic cells, to the study of viral and cellular oncogene action, the immunology and molecular virology of the human immunodeficiency virus and the use of viruses in approaches to the treatment of human malignancies. The research program has proven to be an effective training basis for both predoctoral and postdoctoral trainees. The predoctoral program involves four semesters of academic work followed by a preliminary examination. Upon successful completion of these requirements, full time research occupies the remainder of the training program. The postdoctoral training program is focused on full time research in the participating laboratories. Both the predoctoral and the postdoctoral program are enhanced by departmental and program seminar series of various types as well as departmental retreats and an annual symposium on """"""""pathogenic human viruses."""""""" These activities also foster communication between members of the program to the ultimate benefit of trainees.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Myrick, Dorkina C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Price, Alexander M; Dai, Joanne; Bazot, Quentin et al. (2017) Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection. Elife 6:
Hafez, Amy Y; Luftig, Micah A (2017) Characterization of the EBV-Induced Persistent DNA Damage Response. Viruses 9:
Courtney, David G; Kennedy, Edward M; Dumm, Rebekah E et al. (2017) Epitranscriptomic Enhancement of Influenza A Virus Gene Expression and Replication. Cell Host Microbe 22:377-386.e5
Brandstadter, Joshua D; Chen, Huiyao; Jiang, Songfu et al. (2017) IL-18-dependent NKG2D ligand upregulation on accessory cells is mediated by the PI3K/GSK-3 pathway. J Leukoc Biol 101:1317-1323
Arora, Jay; Sauer, Scott J; Tarpley, Michael et al. (2017) Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies. Oncotarget 8:25848-25863
Han, Sang-Oh; Ronzitti, Giuseppe; Arnson, Benjamin et al. (2017) Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. Mol Ther Methods Clin Dev 4:126-136
Poling, Brigid Chiyoko; Price, Alexander M; Luftig, Micah A et al. (2017) The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis. Virology 512:113-123
Kennedy, Edward M; Courtney, David G; Tsai, Kevin et al. (2017) Viral Epitranscriptomics. J Virol 91:
Sauer, Scott J; Tarpley, Michael; Shah, Imran et al. (2017) Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells. Carcinogenesis 38:252-260
Nicholson, Cindo O; Friedersdorf, Matthew; Keene, Jack D (2017) Quantifying RNA binding sites transcriptome-wide using DO-RIP-seq. RNA 23:32-46

Showing the most recent 10 out of 110 publications